![Overview of PopPK analysis. IIV, inter-individual variability; PopPK,... | Download Scientific Diagram Overview of PopPK analysis. IIV, inter-individual variability; PopPK,... | Download Scientific Diagram](https://www.researchgate.net/publication/350105592/figure/fig1/AS:1002218769616898@1615958983061/Overview-of-PopPK-analysis-IIV-inter-individual-variability-PopPK-population.png)
Overview of PopPK analysis. IIV, inter-individual variability; PopPK,... | Download Scientific Diagram
![PopPK analysis: prediction-corrected visual predictive check for (a)... | Download Scientific Diagram PopPK analysis: prediction-corrected visual predictive check for (a)... | Download Scientific Diagram](https://www.researchgate.net/publication/343531547/figure/fig4/AS:960058108174357@1605907098754/PopPK-analysis-prediction-corrected-visual-predictive-check-for-a-acMMAE-and-b_Q640.jpg)
PopPK analysis: prediction-corrected visual predictive check for (a)... | Download Scientific Diagram
![Simulation results using PK parameters obtained from PopPK analysis... | Download Scientific Diagram Simulation results using PK parameters obtained from PopPK analysis... | Download Scientific Diagram](https://www.researchgate.net/publication/344370348/figure/fig4/AS:960059009941537@1605907313652/Simulation-results-using-PK-parameters-obtained-from-PopPK-analysis-versus-observed.png)
Simulation results using PK parameters obtained from PopPK analysis... | Download Scientific Diagram
![Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661818307503-ga1.jpg)
Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect
![Overview of PopPK analysis. IIV, inter-individual variability; PopPK,... | Download Scientific Diagram Overview of PopPK analysis. IIV, inter-individual variability; PopPK,... | Download Scientific Diagram](https://www.researchgate.net/publication/350105592/figure/fig1/AS:1002218769616898@1615958983061/Overview-of-PopPK-analysis-IIV-inter-individual-variability-PopPK-population_Q640.jpg)
Overview of PopPK analysis. IIV, inter-individual variability; PopPK,... | Download Scientific Diagram
![Pharmaceuticals | Free Full-Text | Population Pharmacokinetic Method to Predict Within-Subject Variability Using Single-Period Clinical Data Pharmaceuticals | Free Full-Text | Population Pharmacokinetic Method to Predict Within-Subject Variability Using Single-Period Clinical Data](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00114/article_deploy/html/images/pharmaceuticals-14-00114-g001.png)
Pharmaceuticals | Free Full-Text | Population Pharmacokinetic Method to Predict Within-Subject Variability Using Single-Period Clinical Data
![Pharmaceutics | Free Full-Text | Matrix Effects of the Hydroethanolic Extract of Calyces of Physalis peruviana L. on Rutin Pharmacokinetics in Wistar Rats Using Population Modeling Pharmaceutics | Free Full-Text | Matrix Effects of the Hydroethanolic Extract of Calyces of Physalis peruviana L. on Rutin Pharmacokinetics in Wistar Rats Using Population Modeling](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-13-00535/article_deploy/html/images/pharmaceutics-13-00535-ag-550.jpg?1628125543)
Pharmaceutics | Free Full-Text | Matrix Effects of the Hydroethanolic Extract of Calyces of Physalis peruviana L. on Rutin Pharmacokinetics in Wistar Rats Using Population Modeling
![Population Pharmacokinetics of an Anti-PD-1 Antibody Camrelizumab in Patients with Multiple tumor types and model informed dosing strategy | bioRxiv Population Pharmacokinetics of an Anti-PD-1 Antibody Camrelizumab in Patients with Multiple tumor types and model informed dosing strategy | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/07/02/2020.06.30.180117/F3.large.jpg)
Population Pharmacokinetics of an Anti-PD-1 Antibody Camrelizumab in Patients with Multiple tumor types and model informed dosing strategy | bioRxiv
![Population Pharmacokinetic Variables: THETA, ETA, EPSILON; and NONMEM for analysis - Pharmacoengineering Population Pharmacokinetic Variables: THETA, ETA, EPSILON; and NONMEM for analysis - Pharmacoengineering](https://i2.wp.com/www.pharmacoengineering.com/wp-content/uploads/2020/09/image-54.png?resize=579%2C363&ssl=1)
Population Pharmacokinetic Variables: THETA, ETA, EPSILON; and NONMEM for analysis - Pharmacoengineering
![Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study | Thrombosis Journal | Full Text Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study | Thrombosis Journal | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12959-018-0185-1/MediaObjects/12959_2018_185_Fig4_HTML.png)
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study | Thrombosis Journal | Full Text
![PopPK analysis: prediction-corrected visual predictive check for (a)... | Download Scientific Diagram PopPK analysis: prediction-corrected visual predictive check for (a)... | Download Scientific Diagram](https://www.researchgate.net/publication/343531547/figure/fig4/AS:960058108174357@1605907098754/PopPK-analysis-prediction-corrected-visual-predictive-check-for-a-acMMAE-and-b.png)
PopPK analysis: prediction-corrected visual predictive check for (a)... | Download Scientific Diagram
![Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661818307503-gr2.jpg)
Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect
![A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism | Journal of Pharmacology and Experimental Therapeutics A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/sites/default/files/highwire/jpet/377/3.cover-source.jpg)
A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism | Journal of Pharmacology and Experimental Therapeutics
![A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism | Journal of Pharmacology and Experimental Therapeutics A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/377/3/305/F1.large.jpg)
A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism | Journal of Pharmacology and Experimental Therapeutics
![Frontiers | Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing—Using Rifampicin as an Example Frontiers | Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing—Using Rifampicin as an Example](https://www.frontiersin.org/files/Articles/512473/fphar-11-00794-HTML/image_m/fphar-11-00794-g001.jpg)